Bayer | BAYN - Market Capitalization


Bayer reported EUR55.61B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 110.58B 17.86B Jun/2026
Akzo Nobel EUR 9.73B 424.21M Sep/2026
Alcon AG USD 28.74B 5.03B Nov/2026
Amarin USD 290M 51M Dec/2025
Arkema EUR 4.37B 151.75M Nov/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
BASF EUR 44.79B 3.03B Sep/2026
Bayer EUR 52.42B 5.31B Nov/2026
Beiersdorf EUR 18.16B 4.56B Jun/2026
Corteva USD 8.34B 48.3B Nov/2026
Essilor EUR 76.16B 48.88B Jun/2026
Fresenius EUR 28.97B 3.77B Nov/2026
Fresenius Medical Care EUR 12.06B 1.43B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Henkel EUR 14.18B 16.9B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Linde USD 224.13B 31.18B Nov/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 64.74B 46.89B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Nutrien USD 49.63B 1.94B Nov/2026
Philips EUR 24.82B 3.69B Nov/2026
PPG Industries USD 23.19B 3.77B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
SAP EUR 164.62B 15.85B Jun/2026
Solvay EUR 2.55B 14.78M Nov/2026
UCB EUR 46.41B 13.94B Dec/2025
Umicore EUR 4.99B 576.58M Jun/2026
Vinci EUR 74.88B 5.03B Jun/2026